Israeli Alzheimer’s Treatment Heads to Clinical Trials

Israeli biopharmaceutical company ImmunoBrain Checkpoint is behind a new technology hailed as a groundbreaking potential treatment for Alzheimer’s. Prof. Michal Schwartz says clinical trials are set to begin soon. Video

November 23, 2021 – 19 Kislev 5782

Israeli biopharmaceutical company ImmunoBrain Checkpoint is behind a new technology hailed as a groundbreaking potential treatment for Alzheimer’s. Prof. Michal Schwartz says clinical trials are set to begin soon. Video

VIDEO: i24News

Never Miss a Headline!

Sign up for the COLlive Daily News Roundup and never miss a story

Opt In

• I would like to receive the collive newsletter

Follow Us!